Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia

Clinical trial NCT04779242 · COMPLETED

Trial details

NCT number: NCT04779242
Sponsor: Paratek Pharmaceuticals Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Community-acquired Pneumonia Bacterial Pneumonia

Start date: 2021-02-25
Primary completion: 2024-03-27
Enrollment: 670

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.